fr   en
Clinical Studies

Browse by date
Or search by keyword
Date: 2006-02-16
Phase: III
Anouncement: Launch
Biotech: Imclone (USA)
Product: Erbitux® (cetuximab)
Disease: metastatic colorectal cancer
Country: international study
Other: Patient recruitment has completed in this study called EPIC, which evaluated the use of the monoclonal antibody for the treatment of the metastatic colorectal cancer after failure of oxaliplatin-based chemotherapy.